The proof-of-concept studies described here show the use of the LuminON system to control the pulsatile and repetitive expression of insulin to enhance blood-glucose homeostasis in T1D mice, which could prevent the hypoglycemia caused by excessive insulin from continuous production by traditional chemical-inducible systems. This evidence concerns the gene INS and Hypoglycemia.